Genetics in medicine : official journal of the American College of Medical Genetics · 2003
Klinefelter syndrome: expanding the phenotype and identifying new research directions.
Conference ProceedingsНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Simpson Joe Leigh, de la Cruz Felix, Swerdloff Ronald S, Samango-Sprouse Carole, Skakkebaek Niels E, Graham John M, Hassold Terry, Aylstock Melissa, Meyer-Bahlburg Heino F L, Willard Huntington F, Hall Judith G, Salameh Wael, Boone Kyle, Staessen Catherine, Geschwind Dan, Giedd Jay, Dobs Adrian S, Rogol Alan, Brinton Bonnie, Paulsen C Alvin
Аннотация
PURPOSE: The purpose of this study is to summarize new data on etiology and clinical features of Klinefelter syndrome in order to derive research priorities.
METHODS: This study was conducted using critical reviews of selective topics, emphasizing less well-recognized clinical findings.
RESULTS AND CONCLUSIONS: The phenotype of the prototypic 47,XXY case is well recognized: seminiferous tubule dysgenesis and androgen deficiency. Less well appreciated is the varied expressivity of 47,XXY Klinefelter syndrome, in particular neurological/cognitive perturbations like language and behavioral problems. Effective therapies are available. Reproductive technologies allow 47,XXY men to sire offspring through intracytoplasmic sperm injection (ICSI); however, genetic counseling is complex and success is low. Behavioral and expressive language difficulties are amenable to treatment by androgen therapy and psychological help. Early treatment may be imperative for optimal outcome.
METHODS: This study was conducted using critical reviews of selective topics, emphasizing less well-recognized clinical findings.
RESULTS AND CONCLUSIONS: The phenotype of the prototypic 47,XXY case is well recognized: seminiferous tubule dysgenesis and androgen deficiency. Less well appreciated is the varied expressivity of 47,XXY Klinefelter syndrome, in particular neurological/cognitive perturbations like language and behavioral problems. Effective therapies are available. Reproductive technologies allow 47,XXY men to sire offspring through intracytoplasmic sperm injection (ICSI); however, genetic counseling is complex and success is low. Behavioral and expressive language difficulties are amenable to treatment by androgen therapy and psychological help. Early treatment may be imperative for optimal outcome.